Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Impact of Osteoporosis Medications on Muscle Health in Older Adults
NCT05666310Phase 4Completed
- Start
- Feb 2023
- Primary completion
- Jan 2026
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid, denosumab in osteoporosis, Sarcopenia. Started Feb 2023; status: completed.
02
Drugs
zoledronic aciddenosumab
03
Conditions
osteoporosisSarcopenia
Beyond the preview
Go deeper on NCT05666310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05666310.